BioCity announces FDA clearance of Investigational New Drug application for its first-in-class CD3/EGFR bispecific antibody ...Middle East

WUXI, China, Aug. 7, 2023 /PRNewswire/ -- BioCity Biopharma today announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Investigational New Drug (IND) application for a Phase 1 study of BC3448 (CD3/EGFR Bispecific antibody, BsAb). As a result, BioCity...

Hence then, the article about biocity announces fda clearance of investigational new drug application for its first in class cd3 egfr bispecific antibody was published today ( Monday 07/08/2023 - 11:17 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( BioCity announces FDA clearance of Investigational New Drug application for its first-in-class CD3/EGFR bispecific antibody )

Also on site :

• 2010s Rock Band Announces Tour for 10th Anniversary of Debut Album
• Nuclear neighbors and a two‑front threat: Why India needs a rocket force
• Greenland hit by power outage, strong winds in wake of US tensions easing